William Mawalla

At present, my research primarily revolves around evaluating treatment outcomes and investigating the effectiveness of liquid biopsies in diagnosing lymphoma in children and young adults within the East African region.

Furthermore, I serve as a member of the Global Partnerships Subcommittee within the International Workshop on CLL (iwCLL) and hold the role of CLL regional champion.

Additionally, I am a co-director for the 'Advancing CLL' Certificate Course, which aims to advance the state-of-the-art CLL diagnosis, management, and clinical research on a global scale, with a particular focus on low- and middle-income countries (LMICs). This course is a collaborative effort involving iwCLL, the University of Oxford, and the Muhimbili University of Health and Allied Sciences (MUHAS).

Dr. William F. Mawalla is a Haematologist and Lecturer at Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania. His passion for advancing healthcare and pioneering solutions has garnered recognition not only within East Africa but also internationally at the University of Oxford in the United Kingdom, where he serves as an Honorary Researcher in collaboration with the Department of Oncology.

Dr. Mawalla wears multiple hats as a researcher, clinician and a healthcare entrepreneur. He is the co-founder and CEO of SerenOx Africa, a healthcare social enterprise. SerenOx Africa stands as the first specialized haematology clinic and laboratory in the region, dedicated to driving progress in haemato-oncological services across East Africa. In partnership with Seren Oxford (a spinout of Oxford University)and local collaborators, SerenOx Africa is committed to making DNA-based diagnostics and rapid point-of-care testing accessible and affordable, with a particular emphasis on enhancing patient outcomes in Sub-Saharan Africa.